COMMUNIQUÉS West-GlobeNewswire
-
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
04/05/2026 -
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
04/05/2026 -
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026 -
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
04/05/2026 -
Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices
04/05/2026 -
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
04/05/2026 -
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04/05/2026 -
MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk
02/05/2026 -
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
02/05/2026 -
Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum
02/05/2026 -
Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation
02/05/2026 -
Avicanna Announces Change in Board of Directors
02/05/2026 -
Pennant Acquires Senior Living Communities in Arizona and Wisconsin
02/05/2026 -
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026 -
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
01/05/2026 -
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
01/05/2026 -
Pacific Health Care Organization, Inc. Reports its First Quarter 2026 Financial Results
01/05/2026 -
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026 -
Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support
01/05/2026
Pages